Central Hemodynamics in Prehypertension: Effect of the β-Adrenergic Antagonist Nebivolol

Journal of Clinical Hypertension

Volumn 15, Issue 1, 2013, Pages 69-74

  Davis, Jason T ^a   Pasha, Dalal N ^a   Khandrika, Srikrishna ^a   Fung, Maple M ^a   Milic, Milos ^a   O'Connor, Daniel T ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE; INTERLEUKIN 6; ISOPROSTANE DERIVATIVE; NEBIVOLOL; NITRIC OXIDE; NITRITE; PLACEBO;

ADULT; AORTA PRESSURE; AORTIC AUGMENTATION INDEX; ARTERY ELASTICITY; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BLOOD ANALYSIS; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ELASTICITY; FEMALE; HEART RATE; HUMAN; MALE; MEAN ARTERIAL PRESSURE; NITRERGIC NERVE; PREHYPERTENSION; PRIORITY JOURNAL; PULSE PRESSURE; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; URINALYSIS; URINARY EXCRETION;

ADOLESCENT; ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; ADULT; BENZOPYRANS; BLOOD PRESSURE; CHI-SQUARE DISTRIBUTION; DOUBLE-BLIND METHOD; ENZYME-LINKED IMMUNOSORBENT ASSAY; ETHANOLAMINES; FEMALE; HEMODYNAMICS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PLACEBOS; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 84871939154     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12031     Document Type: Article

References (43)

1. Chobanian AV, Bakris GL, Black HR, et al.The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2572.
2. Qureshi AI, Suri MF, Kirmani JF, Divani AA. Prevalence and trends of prehypertension and hypertension in United States: National Health and Nutrition Examination Surveys 1976 to 2000. Med Sci Monit. 2005;11:CR403-409.
3. Ishikawa Y, Ishikawa J, Ishikawa S, et al.Prehypertension and the risk for cardiovascular disease in the Japanese general population: the Jichi Medical School Cohort Study. J Hypertens. 2010;28:1630-1637.
4. Drukteinis JS, Roman MJ, Fabsitz RR, et al.Cardiac and systemic hemodynamic characteristics of hypertension and prehypertension in adolescents and young adults: the Strong Heart Study. Circulation. 2007;115:221-227.
5. Julius S, Nesbitt SD, Egan BM, et al.Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med. 2006;354:1685-1697.
6. Vollmer WM, Sacks FM, Ard J, et al.Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial. Ann Intern Med. 2001;135:1019-1028.
7. Davis JT, Rao F, Naqshbandi D, et al.Autonomic and hemodynamic origins of pre-hypertension: central role of heredity. J Am Coll Cardiol. 2012;59:2206-2216.
8. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55:1318-1327.
9. Song BG, Park JB, Cho SJ, et al.Pulse wave velocity is more closely associated with cardiovascular risk than augmentation index in the relatively low-risk population. Heart Vessels. 2009;24:413-418.
10. Roman MJ, Devereux RB, Kizer JR, et al.High central pulse pressure is independently associated with adverse cardiovascular outcome: the Strong Heart Study. J Am Coll Cardiol. 2009;54:1730-1734.
11. Gedikli O, Kiris A, Ozturk S, et al.Effects of prehypertension on arterial stiffness and wave reflections. Clin Exp Hypertens. 2010;32:84-89.
12. Kamp O, Metra M, Bugatti S, et al.Nebivolol: haemodynamic effects and clinical significance of combined beta-blockade and nitric oxide release. Drugs. 2010;70:41-56.
13. Chio SS, Tsai JJ, Hsu YM, et al.Development and validation of a noninvasive method to estimate cardiac output using cuff sphygmomanometry. Clin Cardiol. 2007;30:615-620.
14. Brinton TJ, Cotter B, Kailasam MT, et al.Development and validation of a noninvasive method to determine arterial pressure and vascular compliance. Am J Cardiol. 1997;80:323-330.
15. Fung MM, Rao F, Poddar S, et al.Early inflammatory and metabolic changes in association with AGTR1 polymorphisms in prehypertensive subjects. Am J Hypertens. 2011;24:225-233.
16. Nambiar S, Viswanathan S, Zachariah B, et al.Oxidative stress in prehypertension: rationale for antioxidant clinical trials. Angiology. 2009;60:221-234.
17. Kampus P, Serg M, Kals J, et al.Differential effects of nebivolol and metoprolol on central aortic pressure and left ventricular wall thickness. Hypertension. 2011;57:1122-1128.
18. Chirinos JA, Zambrano JP, Chakko S, et al.Relation between ascending aortic pressures and outcomes in patients with angiographically demonstrated coronary artery disease. Am J Cardiol. 2005;96:645-648.
19. Williams B, Lacy PS, Thom SM, et al.Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation. 2006;113:1213-1225.
20. Wang KL, Cheng HM, Chuang SY, et al.Central or peripheral systolic or pulse pressure: which best relates to target organs and future mortality?J Hypertens. 2009;27:461-467.
21. Elliott WJ, Childers WK. Should beta blockers no longer be considered first-line therapy for the treatment of essential hypertension without comorbidities?Curr Cardiol Rep. 2011;13:507-516.
22. Kelm M. Nitric oxide metabolism and breakdown. Biochim Biophys Acta. 1999;1411:273-289.
23. Gamboa A, Okamoto LE, Diedrich A, et al.Sympathetic activation and nitric oxide function in early hypertension. Am J Physiol Heart Circ Physiol. 2012;302:H1438-1443.
24. Gamboa A, Shibao C, Diedrich A, et al.Contribution of endothelial nitric oxide to blood pressure in humans. Hypertension. 2007;49:170-177.
25. Forte P, Copland M, Smith LM, et al.Basal nitric oxide synthesis in essential hypertension. Lancet. 1997;349:837-842.
26. Owlya R, Vollenweider L, Trueb L, et al.Cardiovascular and sympathetic effects of nitric oxide inhibition at rest and during static exercise in humans. Circulation. 1997;96:3897-3903.
27. Wu TL, Chang PY, Tsao KC, et al.A panel of multiple markers associated with chronic systemic inflammation and the risk of atherogenesis is detectable in asthma and chronic obstructive pulmonary disease. J Clin Lab Anal. 2007;21:367-371.
28. Morrow JD, Frei B, Longmire AW, et al.Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med. 1995;332:1198-1203.
29. Collins C, Tzima E. Hemodynamic forces in endothelial dysfunction and vascular aging. Exp Gerontol. 2011;46:185-188.
30. Vita JA. Nitric oxide and vascular reactivity in African American patients with hypertension. J Card Fail. 2003;9(5 Suppl Nitric Oxide):S199-204; discussion S205-199.
31. Tillin T, Chambers J, Malik I, et al.Measurement of pulse wave velocity: site matters. J Hypertens. 2007;25:383-389.
32. Figueroa A, Sanchez-Gonzalez MA, Perkins-Veazie PM, Arjmandi BH. Effects of watermelon supplementation on aortic blood pressure and wave reflection in individuals with prehypertension: a pilot study. Am J Hypertens. 2011;24:40-44.
33. Celik T, Iyisoy A, Acikel C, et al.The comparative effects of metoprolol and perindopril on aortic elasticity in young patients with prehypertension. Blood Press Monit. 2008;13:169-176.
34. Soanker R, Naidu MU, Raju SB, et al.Effect of beta-1-blocker, nebivolol, on central aortic pressure and arterial stiffness in patients with essential hypertension. Indian J Pharmacol. 2012;44:407-411.
35. Mahmud A, Feely J. Beta-blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection. Am J Hypertens. 2008;21:663-667.
36. Mitchell GF, Parise H, Benjamin EJ, et al.Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study. Hypertension. 2004;43:1239-1245.
37. Collaboration" TRVfAS. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values.'Eur Heart J. 2010;31:2338-2350.
38. Wilkinson IB, MacCallum H, Flint L, et al.The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol. 2000;525(Pt 1):263-270.
39. Smulyan H, Vardan S, Griffiths A, Gribbin B. Forearm arterial distensibility in systolic hypertension. J Am Coll Cardiol. 1984;3(2 Pt 1):387-393.
40. O'Rourke M. Arterial stiffness, systolic blood pressure, and logical treatment of arterial hypertension. Hypertension. 1990;15:339-347.
41. Vyas M, Izzo JL Jr, Lacourciere Y, et al.Augmentation index and central aortic stiffness in middle-aged to elderly individuals. Am J Hypertens. 2007;20:642-647.
42. Wilkinson IB, MacCallum H, Hupperetz PC, et al.Changes in the derived central pressure waveform and pulse pressure in response to angiotensin II and noradrenaline in man. J Physiol. 2001;530(Pt 3):541-550.
43. Kelly RP, Millasseau SC, Ritter JM, Chowienczyk PJ. Vasoactive drugs influence aortic augmentation index independently of pulse-wave velocity in healthy men. Hypertension. 2001;37:1429-1433.